Mendel Money Management Takes Position in Synopsys, Inc. $SNPS

Mendel Money Management purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS) during the third quarter, Holdings Channel reports. The institutional investor purchased 4,505 shares of the semiconductor company’s stock, valued at approximately $2,223,000.

A number of other hedge funds have also bought and sold shares of SNPS. Vanguard Group Inc. lifted its position in shares of Synopsys by 20.7% during the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after acquiring an additional 3,120,401 shares in the last quarter. State Street Corp raised its stake in shares of Synopsys by 1.2% during the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock valued at $3,725,362,000 after purchasing an additional 85,662 shares during the period. Geode Capital Management LLC boosted its stake in Synopsys by 1.5% in the 2nd quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock worth $1,810,214,000 after purchasing an additional 51,043 shares during the period. Ameriprise Financial Inc. grew its holdings in Synopsys by 29.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after buying an additional 585,494 shares in the last quarter. Finally, Alliancebernstein L.P. increased its position in shares of Synopsys by 10.9% during the second quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock valued at $980,757,000 after buying an additional 187,790 shares during the period. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Synopsys

In other news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the sale, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 4,157 shares of company stock worth $1,945,036 over the last ninety days. Insiders own 0.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on SNPS. KeyCorp raised their price objective on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Citigroup assumed coverage on shares of Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 price target for the company. Piper Sandler cut Synopsys from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $602.00 to $520.00 in a research report on Tuesday, January 13th. JPMorgan Chase & Co. lifted their price target on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Finally, Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $553.57.

Synopsys Stock Performance

NASDAQ:SNPS opened at $442.44 on Friday. The company has a market capitalization of $84.65 billion, a price-to-earnings ratio of 55.37, a PEG ratio of 3.68 and a beta of 1.12. The business has a 50 day moving average of $474.32 and a 200 day moving average of $485.28. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period last year, the firm posted $3.40 earnings per share. The business’s revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, sell-side analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.